VIRALEZE sales and distribution in Saudi Arabia and GCC
Filed with ASX · · 3 pages · English
• Starpharma has signed an exclusive sales and distribution agreement for VIRALEZE™ antiviral nasal spray in Saudi Arabia and eight other countries, including the GCC region (United Arab Emirates, Qatar, Kuwait, Oman, and Bahrain) • VIRALEZE™ is already registered for sale in Saudi Arabia, with launch preparations well advanced. The product registration in Saudi Arabia is expected to facilitate fu
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- Starpharma - Quarterly Cashflow and Activities Report
- Starpharma receives $7.7M R&D tax incentive refund
- VIRALEZE successfully launched in Vietnam
- Starpharma signs DEP Research Agreement with US Biopharma Co
- VIRALEZE distribution agreement and launch in Vietnam
Later from Starpharma
- Interim Report and Half-Year Financial Results
- SPL7013 in VIRALEZE virucidal against Omicron
- Application for quotation of securities - SPL
- VIRALEZE to relaunch in the UK
- SPL7013 in VIRALEZE virucidal against influenza A and B
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma